LensCrafters to pay eyeglass customers $39 million over Accufit claims
By Jonathan Stempel NEW YORK LensCrafters agreed to pay $39 million to settle a lawsuit by prescription eyeglass
2023-08-01 23:48
Mexico’s AMLO Proposes Work Training Plan for Foreign Migrants
President Andres Manuel Lopez Obrador said his government may provide labor-training programs for migrants to work on infrastructure
2023-08-01 23:29
Ratings Firms Struggle With Climate Risk in $133 Trillion Market
With 46 straight days of 100-degree heat and coastal waters approaching hot-tub temperatures, Miami can seem like a
2023-08-01 22:57
Chile’s Economy Unexpectedly Expands for First Time Since January
Chile’s economic activity expanded for the first time since January as a surge in mining softened the blow
2023-08-01 21:50
Asset Managers Pledging Climate Action Drop Ball When Investing
Despite commitments to sustainability, BlackRock Inc., Vanguard Group Inc. and Goldman Sachs Group Inc. are among the asset
2023-08-01 21:26
Uber Posts First Operating Profit as Ridership Hits New Record
Uber Technologies Inc. reported its first-ever operating profit, fueled by demand for rides and delivery and marking a
2023-08-01 21:17
CVS to Cut 5,000 Positions in Cost-Reduction Effort
CVS Health Corp. will cut 5,000 positions from its workforce to help reduce costs as the drugstore chain
2023-08-01 20:59
Here's what's in DeSantis' economic plan
Florida Gov. Ron DeSantis is positioning himself as the economic defender of the American family, building on his claim that he is protecting them culturally. The 2024 Republican presidential candidate on Monday released a 10-point economic plan, which he describes as a "Declaration of Economic Independence."
2023-08-01 20:56
Pfizer Misses Quarterly Sales Estimates, Lowering Outlook
Pfizer Inc. missed revenue estimates for the second quarter as sales of its Covid pill fell drastically short
2023-08-01 19:25
Uniper Expects Plan by Year-End for German State Exit
Uniper SE expects the German government to lay out an exit strategy from the company by the end
2023-08-01 18:58
Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
Merck & Co.’s Keytruda and Gardasil soundly beat analysts’ estimates for quarterly sales, driving the company’s annual revenue
2023-08-01 18:56
US, Europe Growing Alarmed by China’s Rush Into Legacy Chips
US and European officials are growing increasingly concerned about China’s accelerated push into the production of older-generation semiconductors
2023-08-01 17:57